Literature DB >> 2117181

Biological activity of bacterial surface components: bacterial extracts and defined bacterial cell wall components as immunomodulators.

W G Bessler1, B Kleine, C Martinez Alonso, L Biesert, M Strecker, K H Wiesmüller, J Metzger, G Jung.   

Abstract

Bacterial extracts obtained from pathogenic strains occurring in lung infections (Broncho Vaxom) or urogenital infections (Urovaxom) as well as defined surface components of Gram-negative bacteria purified from bacteria or obtained by chemical synthesis were tested for their immunomodulatory properties in a murine system. The bacterial extracts were able to act as immunogens inducing an antigen-specific response. Both the bacterial extracts and the purified bacterial cell wall components constituted polyclonal activators of murine splenic B cells, as demonstrated by proliferation assays measuring the incorporation of [3H]thymidine into DNA. They were also able to act as immunoadjuvants increasing the SRBC and the BSA-TNP specific immune response, and could induce tumor cytotoxicity in bone marrow-derived macrophages. The results show that bacterial extracts and defined bacterial surface components constitute immunogens as well as immunomodulators in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117181     DOI: 10.1007/bf02718197

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  20 in total

1.  Activation of natural killer cells and cytokine production in man by bacterial extracts.

Authors:  J Wybran; M Libin; L Schandene
Journal:  Immunopharmacol Immunotoxicol       Date:  1989       Impact factor: 2.730

2.  Induction of tumor cytotoxicity in murine bone marrow-derived macrophages by two synthetic lipopeptide analogues.

Authors:  P Hoffmann; K H Wiesmüller; J Metzger; G Jung; W G Bessler
Journal:  Biol Chem Hoppe Seyler       Date:  1989-06

3.  Lipopeptides of the N-terminus of Escherichia coli lipoprotein: synthesis, mitogenicity and properties in monolayer experiments.

Authors:  W Prass; H Ringsdorf; W Bessler; K H Wiesmüller; G Jung
Journal:  Biochim Biophys Acta       Date:  1987-06-12

4.  Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides.

Authors:  J Andersson; O Sjöberg; G Möller
Journal:  Eur J Immunol       Date:  1972-08       Impact factor: 5.532

5.  A synthetic analogue of Escherichia coli lipoprotein, tripalmitoyl pentapeptide, constitutes a potent immune adjuvant.

Authors:  A Lex; K H Wiesmüller; G Jung; W G Bessler
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

6.  Specific antibodies elicited by antigen covalently linked to a synthetic adjuvant.

Authors:  W G Bessler; B Suhr; H J Bühring; C P Muller; K H Wiesmüller; G Becker; G Jung
Journal:  Immunobiology       Date:  1985-09       Impact factor: 3.144

7.  Enhancement of cytokine production and natural killer activity by an Escherichia coli extract.

Authors:  J Wybran; M Libin; L Schandene
Journal:  Onkologie       Date:  1989-06

8.  Synthetic lipopeptide analogs of bacterial lipoprotein are potent polyclonal activators for murine B lymphocytes.

Authors:  W G Bessler; M Cox; A Lex; B Suhr; K H Wiesmüller; G Jung
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

9.  Protein I and protein II from the outer membrane of Escherichia coli are mouse B-lymphocyte mitogens.

Authors:  W G Bessler; U Henning
Journal:  Z Immunitatsforsch Immunobiol       Date:  1979-06

10.  Lipopeptide derivatives of bacterial lipoprotein constitute potent immune adjuvants combined with or covalently coupled to antigen or hapten.

Authors:  A Reitermann; J Metzger; K H Wiesmüller; G Jung; W G Bessler
Journal:  Biol Chem Hoppe Seyler       Date:  1989-04
View more
  12 in total

1.  Vaccine Development for the Prevention of Urinary Tract Infections.

Authors:  Walter J. Hopkins; David T. Uehling
Journal:  Curr Infect Dis Rep       Date:  2002-12       Impact factor: 3.725

2.  Induction of interleukin 6 and interleukin 8 expression by Broncho-Vaxom (OM-85 BV) via C-Fos/serum responsive element.

Authors:  R Keul; M Roth; E Papakonstantinou; M Nauck; A P Perruchoud; L H Block
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

3.  Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 binding cytokines.

Authors:  M Roth; L H Block
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

4.  Anti-inflammatory effect of an Escherichia coli extract in a mouse model of lipopolysaccharide-induced cystitis.

Authors:  Seung-Ju Lee; Sae Woong Kim; Yong-Hyun Cho; Moon Soo Yoon
Journal:  World J Urol       Date:  2005-12-31       Impact factor: 4.226

5.  Presence of hsp65 in bacterial extracts (OM-89): a possible mediator of orally-induced tolerance?

Authors:  B S Polla; S Baladi; K Fuller; G Rook
Journal:  Experientia       Date:  1995-08-16

6.  Intranasal immunization with a colloid-formulated bacterial extract induces an acute inflammatory response in the lungs and elicits specific immune responses.

Authors:  A Rial; D Lens; L Betancor; H Benkiel; J S Silva; J A Chabalgoity
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

7.  The polybacterial lysate Olimunostim modulates lymphocyte function in vitro and restores depressed cellular immunity in vivo.

Authors:  M Petrek; E Weigl; M Ordeltová
Journal:  Folia Microbiol (Praha)       Date:  1994       Impact factor: 2.099

8.  In vitro Superoxide Production by Peripheral Neutrophils from Patients with Inflammatory Bowel Disease.

Authors:  O H Nielsen; D Berild; I Ahnfelt-Rønne
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

9.  Inhibiting avian influenza virus shedding using a novel RNAi antiviral vector technology: proof of concept in an avian cell model.

Authors:  Lyndsey M Linke; Jeffrey Wilusz; Kristy L Pabilonia; Johannes Fruehauf; Roberta Magnuson; Francisco Olea-Popelka; Joni Triantis; Gabriele Landolt; Mo Salman
Journal:  AMB Express       Date:  2016-02-24       Impact factor: 3.298

10.  Effects of the Bacterial Extract OM-85 on Phagocyte Functions and the Stress Response.

Authors:  S Baladi; S Kantengwa; Y R Donati; B S Polla
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.